The epilepsy treatment market is a rapidly evolving sector of the pharmaceutical and medical devices industry that focuses on developing and providing therapeutic solutions for individuals living with epilepsy, a neurological disorder characterized by recurrent seizures. The market has witnessed significant advancements in recent years, driven by growing awareness, increasing research and development activities, and improved understanding of the underlying mechanisms of epilepsy. As a result, there is a wide range of treatment options available, including antiepileptic drugs (AEDs), surgical interventions, and neuromodulation therapies. One of the key drivers of the epilepsy treatment market's growth is the rising prevalence of epilepsy worldwide. According to the World Health Organization (WHO), approximately 50 million people live with epilepsy, making it one of the most common neurological disorders globally. The increasing incidence of epilepsy has spurred subs
Market research reports, analysis, insights and business intelligence